Migraine treatment and placebo effect

被引:14
作者
Speciali, Jose G. [1 ]
Peres, Mario [2 ]
Bigal, Marcelo E. [3 ,4 ]
机构
[1] Univ Sao Paulo, Dept Neurol, Sch Med Ribeirao Preto, Sao Paulo, Brazil
[2] Albert Einstein Med Hosp, Div Neurol, Sao Paulo, Brazil
[3] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA
[4] Merck Res Labs, Whitehouse Stn, NJ USA
关键词
acute treatment; migraine; placebo; placebo effect; preventive treatment; BLIND CLINICAL-TRIALS; TOXIN TYPE-A; PROPHYLACTIC TREATMENT; PARALLEL-GROUP; MULTICENTER; HEADACHE; ACUPUNCTURE; MECHANISMS; ANALGESIA; EFFICACY;
D O I
10.1586/ERN.10.8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Placebos are typically defined as physiologically inactive substances that elicit a therapeutic response. The antipode of the placebo effect is the nocebo effect, or the negative effects of placebo, where unpleasant symptoms (e.g., adverse events) emerge after the administration of placebo. Placebo analgesia is one of the most striking examples of the cognitive modulation of pain perception. Herein we focus on the importance of placebo in headache research. We first review the mechanisms of the placebo effect. We then focus on the importance of placebo in the acute treatment of migraine. We follow by discussing the importance of placebo on the preventive treatment of migraine and our perspectives for the 5 years to come regarding the study of the placebos.
引用
收藏
页码:413 / 419
页数:7
相关论文
共 50 条
[41]   Phase 2 randomized placebo-controlled study of lasmiditan for the acute treatment of migraine in Japanese patients [J].
Sakai, Fumihiko ;
Takeshima, Takao ;
Homma, Gosuke ;
Tanji, Yuka ;
Katagiri, Hideaki ;
Komori, Mika .
HEADACHE, 2021, 61 (05) :755-765
[42]   Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial [J].
Lipton, Richard B. ;
Munjal, Sagar ;
Dodick, David W. ;
Tepper, Stewart J. ;
Serrano, Daniel ;
Iaconangelo, Charlie .
JOURNAL OF PAIN RESEARCH, 2021, 14 :549-560
[43]   Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins [J].
Schaefer, Sara M. ;
Gottschalk, Christopher H. ;
Jabbari, Bahman .
TOXINS, 2015, 7 (07) :2615-2628
[44]   Pharmacological options for the treatment of chronic migraine pain [J].
Urits, Ivan ;
Gress, Kyle ;
Charipova, Karina ;
Zamarripa, Alec M. ;
Patel, Parth M. ;
Lassiter, Grace ;
Jung, Jai Won ;
Kaye, Alan D. ;
Viswanath, Omar .
BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2020, 34 (03) :383-407
[45]   Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos [J].
A. J. M. de Craen ;
J. G. P. Tijssen ;
J. de Gans ;
J. Kleijnen .
Journal of Neurology, 2000, 247 :183-188
[46]   Intravenous ibuprofen for acute treatment of migraine: A double-blind, randomized, placebo-controlled pilot study [J].
Yuan, Hsiangkuo ;
Curran, John G. ;
Keith, Scott W. ;
Hopkins, Mary M. ;
Silberstein, Stephen D. .
HEADACHE, 2021, 61 (09) :1432-1440
[47]   Treatment of Comorbid Migraine and Temporomandibular Disorders: A Factorial, Double-Blind, Randomized, Placebo-Controlled Study [J].
Goncalves, Daniela A. G. ;
Camparis, Cinara M. ;
Speciali, Jose G. ;
Castanharo, Sabrina M. ;
Ujikawa, Liliana T. ;
Lipton, Richard B. ;
Bigal, Marcelo E. .
JOURNAL OF OROFACIAL PAIN, 2013, 27 (04) :325-335
[48]   Topiramate Treatment of Chronic Migraine: A Randomized, Placebo-Controlled Trial of Quality of Life and Other Efficacy Measures [J].
Silberstein, Stephen ;
Lipton, Richard ;
Dodick, David ;
Freitag, Fred ;
Mathew, Ninan ;
Brandes, Jan ;
Bigal, Marcelo ;
Ascher, Steven ;
Morein, Jacqueline ;
Wright, Pamela ;
Greenberg, Steven ;
Hulihan, Joseph .
HEADACHE, 2009, 49 (08) :1153-1162
[49]   Botulinum Toxin versus Placebo: A Meta-Analysis of Prophylactic Treatment for Migraine [J].
Bruloy, Eva ;
Sinna, Raphael ;
Grolleau, Jean-Louis ;
Bout-Roumazeilles, Apolline ;
Berard, Emilie ;
Chaput, Benoit .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2019, 143 (01) :239-250
[50]   Treatment of Chronic Migraine [J].
Diener, Hans-Christoph ;
Holle, Dagny ;
Dodick, David .
CURRENT PAIN AND HEADACHE REPORTS, 2011, 15 (01) :64-69